Related Experiment Videos
Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis
1Department of Internal Medicine, Clinical Research Institute, Medical Research Center, Seoul National University College of Medicine, 28 Yungon-dong, Chongno-gu, Seoul 110-744, Korea.
Tissue Antigens
|April 24, 2004
Summary
This study investigated transforming growth factor-beta1 (TGF-beta1) gene variations in Korean systemic sclerosis (SSc) patients. No significant differences in TGF-beta1 gene polymorphisms were observed between patients and healthy controls.
Area of Science:
- Immunogenetics
- Rheumatology
- Molecular Biology
Background:
- Transforming growth factor-beta1 (TGF-beta1) is implicated in the pathogenesis of systemic sclerosis (SSc).
- Investigating gene polymorphisms can elucidate disease associations.
- Understanding genetic factors in SSc is crucial for developing targeted therapies.
Purpose of the Study:
- To examine the association between TGF-beta1 gene polymorphisms and SSc in a Korean population.
- To determine if specific TGF-beta1 genetic variations are risk factors for SSc.
Main Methods:
- Genotyping of six biallelic polymorphic positions in the TGF-beta1 gene using polymerase chain reaction-sequence-specific primers.
- Study included 61 Korean SSc patients and 148 healthy controls.
- Analysis of allele frequencies at positions -509 and codon 10.
Main Results:
- Genetic polymorphisms in TGF-beta1 were identified at position -509 and codon 10 in the Korean population.
- Allele frequencies at position -509 (C/T) were 0.59/0.41 in patients and 0.56/0.44 in controls.
- Allele frequencies at codon 10 (C/T) were 0.40/0.60 in patients and 0.50/0.50 in controls.
Conclusions:
- No skewed distribution of TGF-beta1 gene polymorphisms was found in Korean patients with SSc.
- The studied TGF-beta1 polymorphisms do not appear to be associated with SSc susceptibility in this Korean cohort.
- Further research with larger cohorts may be warranted to explore other genetic factors.